안과 수술 시장 : 제품 유형, 수술 유형, 기술, 최종 사용자별 예측(2026-2032년)

The Eye Care Surgical Market is projected to grow by USD 12.22 billion at a CAGR of 10.46% by 2032.

Eye care surgical services are becoming a core pillar of global health systems as aging populations, diabetes prevalence, and rising demand for cataract surgery, refractive surgery, glaucoma procedures, corneal transplantation, and retinal surgery expand the addressable patient base.

The World Health Organization estimates that at least 2.2 billion people have near or distance vision impairment, and at least 1 billion cases are preventable or not yet addressed. Cataract and uncorrected refractive error remain among the leading avoidable causes of vision loss, making ophthalmic surgery a high-priority area for hospitals, ambulatory surgery centers, ophthalmologists, medical device suppliers, and public health agencies focused on restoring sight, improving productivity, and reducing long-term disability.

Transformative Shifts in the Eye Care Surgical Landscape

The eye care surgical landscape is shifting from inpatient ophthalmology toward high-throughput, technology-enabled, outpatient surgery models. Cataract surgery remains the highest-volume ophthalmic procedure globally, while minimally invasive glaucoma surgery, premium intraocular lenses, femtosecond laser-assisted cataract surgery, corneal procedures, and advanced retinal interventions are reshaping treatment pathways.

Health systems are also prioritizing surgical efficiency, infection prevention, shorter recovery times, and measurable clinical outcomes. Ambulatory surgery centers are gaining relevance in mature markets, while emerging economies are expanding surgical access through public-private programs, specialty eye hospitals, outreach initiatives, and training networks. These changes are creating demand for integrated ophthalmic platforms, surgeon education, precision diagnostics, and value-based procurement.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing preoperative screening, diagnostic imaging interpretation, surgical planning, workflow management, and postoperative monitoring. AI-enabled analysis of optical coherence tomography, fundus imaging, biometry, visual fields, and electronic health records can support earlier detection of diabetic retinopathy, glaucoma progression, cataract severity, and macular disease.

In surgery, AI is most valuable when paired with validated clinical oversight. Its near-term impact is concentrated in case prioritization, intraocular lens power calculation support, complication risk stratification, operating room scheduling, image-guided decision support, and remote follow-up. Adoption will depend on clinical validation, cybersecurity, reimbursement clarity, representative data quality, explainability, and regulatory compliance.

Key Regional Insights

Asia-Pacific is a major growth engine because China, India, Japan, South Korea, and Australia combine large aging populations with expanding ophthalmology infrastructure, strong cataract surgery demand, and increasing use of diagnostic imaging and intraocular lens technologies. North America benefits from advanced ambulatory surgery center networks, high ophthalmologist specialization, premium intraocular lens adoption, and established reimbursement pathways, particularly in the United States and Canada.

Europe maintains high procedural standards through national health systems, private specialty providers, medical device regulation, and broad access to cataract and retinal care, although wait-time pressures remain relevant in several countries. Latin America is improving access through Brazil and Mexico-led investments in specialty care, urban ophthalmology clinics, and public eye health programs. The Middle East, especially GCC markets, is prioritizing specialty hospitals, advanced ophthalmic equipment, and medical tourism, while Africa's progress is closely tied to cataract outreach, workforce expansion, surgical affordability, and partnerships that address avoidable blindness in underserved communities.

Key Group Insights

ASEAN markets are expanding surgical capacity through urban specialty hospitals, national blindness-prevention programs, and public eye health initiatives that target cataract, diabetic eye disease, and refractive needs. The GCC is investing in premium ophthalmology, advanced diagnostic imaging, specialty hospitals, and cross-border care, supported by rising demand for high-acuity and elective procedures. The European Union supports standardized safety expectations, medical device regulation, cross-country clinical collaboration, and evidence-based procurement across ophthalmic technologies.

BRICS countries represent large unmet surgical need and domestic manufacturing opportunities, especially in China, India, and Brazil, where population scale and public health priorities are increasing demand for affordable cataract surgery, glaucoma care, retinal treatment, and diagnostic access. G7 countries lead in innovation, reimbursement sophistication, clinical trial activity, quality reporting, and adoption of advanced surgical platforms. NATO member markets overlap significantly with high-income healthcare systems where surgical resilience, supply chain security, cybersecurity, and medical technology availability are strategic priorities for ophthalmic care continuity.

Key Country Insights

The United States remains a leading country for cataract surgery, refractive procedures, retinal surgery, glaucoma interventions, and ambulatory ophthalmic care, supported by a mature specialist base and strong uptake of advanced surgical technologies. Canada emphasizes public coverage, equitable access, and wait-time management, while Mexico and Brazil are expanding private specialty services alongside persistent public care needs and growing demand for cataract, retina, and refractive services.

In Europe, the United Kingdom, Germany, France, Italy, and Spain support mature cataract and retinal procedure volumes through established ophthalmology networks, national health coverage, and private care pathways, while Russia maintains demand across large urban ophthalmology centers. China and India face high population-driven need, diabetes-related eye disease, cataract burden, and rapid infrastructure growth, making surgical access and workforce scale central priorities. Japan, South Korea, and Australia benefit from advanced technology adoption, aging demographics, established specialist networks, and strong use of diagnostic imaging and precision surgical planning.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize surgical access, clinical outcomes, and operational efficiency. Providers can expand ambulatory eye surgery capacity, standardize infection control, invest in surgeon training, reduce avoidable delays, and use diagnostics to identify treatable disease earlier.

Manufacturers should focus on reliable phacoemulsification systems, premium and monofocal intraocular lenses, retinal instruments, glaucoma implants, surgical visualization tools, digital microscopes, ophthalmic imaging systems, and interoperable data platforms. Leaders should also strengthen regulatory readiness, local partnerships, AI governance, reimbursement evidence, quality reporting, supply chain resilience, and post-market surveillance to support scalable, trusted adoption.

Research Methodology

This executive summary is based on triangulation of publicly available, authoritative sources, including the World Health Organization, International Agency for the Prevention of Blindness, national health agencies, regulatory databases, peer-reviewed ophthalmology literature, demographic datasets from the United Nations, diabetes burden data, and medical technology industry disclosures.

The analysis combines disease burden, procedure trends, demographic indicators, technology adoption signals, regulatory context, reimbursement environment, and regional healthcare infrastructure. Insights are validated through cross-source consistency checks and exclude unverified market-size, market-share, and forecasting claims, ensuring that conclusions remain data-backed, practical, and relevant to eye care surgical decision-makers.

Conclusion

The eye care surgical market is positioned for durable expansion as preventable blindness, cataract burden, diabetes-related eye disease, glaucoma, and age-related retinal disorders increase worldwide. Demand is strongest where surgical infrastructure, skilled ophthalmologists, reimbursement, diagnostic access, and patient referral pathways align.

Future competitiveness will depend on the ability to deliver high-quality eye surgery at scale. Organizations that combine affordable access, precision diagnostics, AI-supported workflows, resilient supply chains, clinical governance, and measurable outcomes will be best placed to capture demand while improving global vision health.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Eye Care Surgical Market, by Product Type

• 7.1. Surgical Equipment
  • 7.1.1. Phaco Machines
  • 7.1.2. Vitrectomy Systems
• 7.2. Implants
  • 7.2.1. Intraocular Lenses
  • 7.2.2. Glaucoma Stents
• 7.3. Consumables
• 7.4. Surgical Instruments

8. Eye Care Surgical Market, by Procedure Type

• 8.1. Cataract Surgery
  • 8.1.1. Extracapsular Extraction
  • 8.1.2. Intracapsular Extraction
  • 8.1.3. Phacoemulsification
• 8.2. Glaucoma Surgery
  • 8.2.1. Minimally Invasive Glaucoma Surgery
  • 8.2.2. Trabeculectomy
  • 8.2.3. Tube Shunt
• 8.3. Refractive Surgery
• 8.4. Vitreoretinal Surgery
  • 8.4.1. Macular Surgery
  • 8.4.2. Pars Plana Vitrectomy
  • 8.4.3. Retinal Detachment Repair

9. Eye Care Surgical Market, by Technology

• 9.1. Incision Based
  • 9.1.1. Manual Small Incision
  • 9.1.2. Phacoemulsification
• 9.2. Laser Based
  • 9.2.1. Excimer
  • 9.2.2. Femtosecond

10. Eye Care Surgical Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Hospitals
• 10.3. Ophthalmic Clinics

11. Eye Care Surgical Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Eye Care Surgical Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Eye Care Surgical Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Alcon Inc.
• 15.2. Bausch + Lomb Corporation
• 15.3. Bausch+Lomb Incorporated
• 15.4. Carl Zeiss AG
• 15.5. Duckworth & Kent Ltd.
• 15.6. Ellex Medical Pty Ltd
• 15.7. GE Healthcare
• 15.8. Geuder AG
• 15.9. Halma PLC
• 15.10. HOYA Corporation
• 15.11. Iridex Corporation
• 15.12. Johnson & Johnson Services Inc.
• 15.13. LENSAR, Inc.
• 15.14. Mani, Inc.
• 15.15. Medtronic plc
• 15.16. NIDEK Co., Ltd.
• 15.17. Oertli Instrumente AG
• 15.18. Rumex International Co.
• 15.19. Sklar Surgical Instruments, Inc.
• 15.20. Sontec Instruments, Inc.
• 15.21. SurgiEdge Corporation
• 15.22. Surgitrac Instruments (UK) Ltd.
• 15.23. Topcon Corporation